At the University of Missouri, researchers are studying how a common medication can be repurposed to help improve gut health in people with autism. A new pilot study from Mizzou suggests that propranolol, a common blood pressure ...
2 minutes ago
0
0
Research led by Memorial Sloan Kettering Cancer Center (MSK) is shedding new light on how ovarian cancer evolves—insights that could help researchers develop more effective treatment strategies.
4 minutes ago
0
0
Autism is a neurodevelopmental condition that affects how people's brains develop and function, impacting behavior, communication and socializing. It can also involve differences in the way you move and walk—known as your ...
37 minutes ago
0
0
All day long, our brains carry out complicated and energy-intensive tasks such as remembering, solving problems, and making decisions.
1 hour ago
0
1
New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse models, investigators demonstrated that inhibiting GLUD1 ...
1 hour ago
0
0
A research team has identified, for the first time in humans, and in a realistic environment, a key neurophysiological mechanism in memory formation: ripple-type brain waves—high-frequency electrical oscillations that mark ...
1 hour ago
0
0
In the last decade, the incidence of restrictive eating disorders in children, like anorexia-nervosa and avoidant/restrictive food intake disorders (ARFID), has doubled. These disorders have severe consequences for growing ...
From the moon landing to the Kennedy assassination and, most recently, to the fate of Jeffrey Epstein and his alleged client list, conspiracy theories have long captivated Americans' attention.
1 hour ago
0
0
More than 10,000 adults each day are celebrating their birthdays with 65 candles on the cake. Although that may be a cause for alarm for some, it's never too late to develop healthy aging habits and change mindsets on aging, ...
1 hour ago
0
0
A new study published in the Journal of Cancer Survivorship sheds light on the value of a novel peer psychosocial support for breast cancer patients in Adama, Ethiopia.
1 hour ago
0
0
Charcot–Marie–Tooth disease- (CMT), known also as Morbus Charcot-Marie-Tooth, Charcot-Marie-Tooth neuropathy, hereditary motor and sensory neuropathy (HMSN), hereditary sensorimotor neuropathy (HSMN), or peroneal muscular atrophy, is an inherited disorder of nerves (neuropathy) that takes different forms. It is predominantly characterized by loss of muscle tissue and touch sensation, in the feet, ankles and legs as it progresses over time, but also in the hands, wrists and arms in various types of the disease. Early and late onset forms occur with 'on and off' painful spasmodic muscular contractions that can be disabling when the disease activates. High arched 'Cavus Feet' are associated with the disorder. Sensory and positioning nerves in the hands and feet are often damaged, while pain nerves are left intact. Overuse of an affected hand or limb can activate symptoms ranging from numbness, to spasm, to very painful cramping. Currently incurable, this disease is one of the most common inherited neurological disorders, and was considered a type of Muscular Dystrophy for years.
Estimates of incidence vary widely from 1 in 380,000 people affected to 1 in 2,500 people affected [1]. This larger figure might equate to approximately 23,000 people in the UK and 125,000 people in the USA.
This text uses material from Wikipedia licensed under CC BY-SA
